Rocuronium Other names: Rocuronium bromide

Chemical formula: C₃₂H₅₃N₂O₄+ Molecular mass: 529.774 g/mol PubChem compound: 441290

Therapeutic indications

Rocuronium is indicated for:

Facilitation of tracheal intubation to general anaesthesia

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Rocuronium bromide is as an adjunct to general anaesthesia to facilitate tracheal intubation during routine sequence induction and to provide skeletal muscle relaxation during surgery.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.6 mg/kg and thereafter 0.15 mg/kg or 0,075-0,1 mg/kg in the case of long-term inhalational anaesthesia

Facilitation of tracheal intubation during rapid sequence induction, adjunct in the intensive care unit (ICU)

Population group: only adults (18 - 65 years old)

In adults rocuronium bromide is also indicated to facilitate tracheal intubation during rapid sequence induction and as an adjunct in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.6 mg/kg followed by a continuous infusion for the maintenance of a neuromuscular block of 80-90%

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.